AQST Aquestive Therapeutics, Inc.

$4.78▼ -4.21% Healthcare Other
After hours $4.78▲ +0.00% Sep 11, 7:39 PM ET
Volume 4.14M Avg Volume (10D) 2.32M
Key Metrics & Fundamentals
Market Cap
$599.95M
P/E Ratio
–
Div Yield
–%
52W Range
2.93 - 7.55
% vs 50 MA
9.46%
% vs 200 MA
7.42%
RSI-14
49.5
MACD Histogram
-0.0500
Beta (1Y vs SPY)
0.90
Free Cash Flow
-$9.65M
Gross Rev
$13.82M
Gross Profit
$9.80M
EBITDA
-$7.21M
COGS
$4.02M
Operating Exp
$18.03M
Operating Income
-$8.22M
EBIT
-$8.22M
Pretax Income
-$22.86M
Net Income
-$22.86M
EPS (Diluted)
-0.18
Price & Volume History
Loading chart…
Recent News
Aquestive Therapeutics (AQST): Second Chance At Anaphylm Comes Into Focus
Insider Monkey · Sep 8, 2026 2:07 AM
Aquestive Therapeutics to Participate in Upcoming September Investor Conferences
GlobeNewswire · Sep 1, 2026 11:00 AM
Aquestive (AQST) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 18, 2026 11:31 PM
Aquestive Therapeutics Inc (AQST) (Q2 2026) Earnings Call Highlights: Anaphylm Resubmission on ...
GuruFocus.com · Aug 12, 2026 11:04 PM
Aquestive Therapeutics Q2 Earnings Call Highlights
MarketBeat · Aug 12, 2026 2:05 PM
Aquestive Therapeutics, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 12, 2026 12:30 PM
Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 11, 2026 9:25 PM
Aquestive Therapeutics Q2 Loss Widens, Revenue Rises
MT Newswires · Aug 11, 2026 8:49 PM
Aquestive Therapeutics: Q2 Earnings Snapshot
Associated Press · Aug 11, 2026 8:22 PM
Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 11, 2026 8:01 PM
Financial Overview - Income Statement Quarterly

See AQST's money flow as a full page

Social Sentiment
Avg +0.10 · 4 posts
FDA just published the full CRL for AQST / Anaphylm - Showing critical issues that AQST tried to downplay
r/stocks · Mar 5, 2026
The post highlights 'critical issues' AQST tried to downplay, indicating a negative sentiment regarding the company's prospects.
negative -0.80
TradeDiscussionStrongest stocks 45 minutes after open
r/StockMarket · Feb 2, 2026
AQST is identified as a top performer, generating positive sentiment.
positive +0.50
DDNewsDiscussion🚨 $AQST DD 🚨 Battle of the Drug Dealers: $AQST vs $SPRY vs Epipen (FDA Jan 31 Catalyst)
r/wallstreetbets · Sep 24, 2025
The post focuses on AQST as part of a comparative analysis and potential catalyst.
positive +0.60
DDDiscussionAQST - Helping your allergen ridden customers from getting you sick.
r/wallstreetbets · Sep 7, 2025
The post is a highly negative and hyperbolic scenario, fueled by a sarcastic and alarming situation. It's a creative, but unsettling, hypothetical.
negative +0.10
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙